Zynerba Pharmaceuticals, Inc. ZYNE
1.30 +1.30
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2022 · select a line to chart its full history
Income statement
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| -35.25M | -36.77M | -52.06M | -34.32M | -40.40M | |
| -35.04M | -37.31M | -51.34M | -32.94M | -39.91M | |
| -0.82 | -0.95 | -1.90 | -1.50 | -2.61 |
Balance sheet
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 50.64M | 67.81M | 59.16M | 70.06M | 59.76M | |
| 55.52M | 81.17M | 74.06M | 87.76M | 67.33M | |
| 9.29M | 10.26M | 13.91M | 12.17M | 9.73M | |
| 334.43K | 562.76K | 109.69K | 353.37K | 0 | |
| 46.23M | 70.91M | 60.14M | 75.60M | 57.60M |
Cash flow
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| -23.03M | -33.46M | -41.31M | -34.82M | -32.40M | |
| -154.10K | -47.57K | -445.31K | -129.39K | -286.66K | |
| 6.01M | 42.16M | 30.85M | 45.25M | 29.94M | |
| -154.10K | -47.57K | -445.31K | -129.39K | -286.66K | |
| -17.17M | 8.65M | -10.91M | 10.30M | -2.75M |